Table 1 Clinicopathological characteristics of the patients with male breast cancer
age | TNM classification | histology | ER (%) | PgR (%) | HER2 (FISH) | AR (%) | Ki-67 (%) | Histological grade | Radiation | Adjuvant therapy | Follow up (months), Outcome |
|---|---|---|---|---|---|---|---|---|---|---|---|
47 | T2N0M0 | IDC | 99 | 80 | 1+ | 60 | 50 | 2 (2/3/1) | – | pre; TC (4) post; cape+TAM | 8 |
58 | T1bN0M0 | IDC | 99 | 40 | 1+ | 20 | 20 | 2 (3/2/1) | – | post; TAM | 27 |
63 | T1aN0M0 | IDC | 99 | 80 | 1+ | 90 | 10 | 1 (2/2/1) | 60Gy/30fr (WBRT) | – | 48 |
63 | T1cN0M0 | IDC | 90 | 80 | 2+ (1.54) | 95 | 70 | 3 (3/2/3) | – | post; TAM | 90 |
69 | T3N3aM0 | IDC | 90 | 0 | 1+ | 95 | 10 | 3 (3/3/2) | – | post; CEF (2) MBC; TOR + 5’DFUR wPTX | 76 deceased |
72 | T2N3aM0 | IDC | 99 | 90 | 2+ (2.26) | 90 | 30 | 2 (3/2/1) | 50Gy/25fr (PMRT) | pre; wPTX + trastuzumab (4) post; TAM + trastuzumab (13) | 14 |
74 | T2N0M0 | IDC | 95 | 95 | 0 | 95 | 15 | 1 (2/2/1) | – | post; TAM | 56 Local recurrence, bone meta at 24 months |
74 | T2N0M0 | mucinous | 80 | 80 | 0 | 80 | < 1 | – | – | post; TAM | 57 |